BGM Group Ltd. BGM

NASDAQ BGM
$8.97 +0.03 (+0.34%)
As of: Oct 19, 2026 · 3:49 PM EDT

BGM Group Ltd. (BGM) stock price is $8.97, up 0.34% on the day, as of Oct 19, 2026. It has a market cap of $33.87Mn, and is classified in the Generic Drugs industry (Healthcare sector).

Key Stats
Market Cap33.87 Mn
Div. Yield0.00
Total Debt (Qtr)1.08 Mn
Add ratio to table…

About

BGM Group Ltd is a Cayman Islands holding company that conducts its pharmaceutical and chemical business in China through contractual arrangements with Gansu Qilianshan Pharmaceutical Co., Ltd. and its subsidiaries. The company focuses on the development manufacture marketing and sale of products such as oxytetracycline licorice extracts traditional Chinese medicine derivatives heparin sausage casings and fertilizers while also pursuing initiatives in artificial intelligence…

Read more ↓
Sectors: Healthcare Basic Materials Sector rationale The company's primary revenue is generated from the manufacture and sale of pharmaceuticals, including oxytetracycline tablets, licorice products, and heparin, which fall under the Healthcare sector. A secondary sector of Basic Materials is justified because the company also manufactures and sells fertilizers, which is explicitly listed as an in-scope industry for Basic Materials. Industries: Generic Drugs Generic Drugs Primary The company manufactures and sells oxytetracycline tablets, licorice products, and heparin, which are specialty and generic pharmaceutical products. It sells these to a large network of distributors and dealers across China. Fertilizers Fertilizers Secondary The company explicitly lists fertilizers as one of its core products and identifies a specific customer base of thirty-two dealers for fertilizer products. Classified using BQ-MICS CIK: 0001779578

Segments Breakdown of Revenue (2025)

History
Peer group

Peer Comparison

Companies in the Generic Drugs
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 LLY ELI LILLY & Co 1,109.83 Bn41.5513.9354.91 Bn
2 JNJ Johnson & Johnson 610.61 Bn29.036.2449.04 Bn
3 ABBV AbbVie Inc. 500.66 Bn79.347.7870.82 Bn
4 MRK Merck & Co., Inc. 354.64 Bn111.775.3353.91 Bn
5 NVS Novartis Ag 291.14 Bn18.465.329.59 Bn
6 AZN Astrazeneca Plc 254.18 Bn24.334.3332.35 Bn
7 AMGN Amgen Inc 229.46 Bn26.246.0257.30 Bn
8 BGM BGM Group Ltd. 0.03 Bn--0.00 Bn